This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Novartis Ag. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Eusebio Manchado Robles: Innovator in Cancer Treatment
Introduction
Eusebio Manchado Robles is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies.
Latest Patents
Eusebio holds a patent for "Antibodies to PMEL17 and conjugates thereof." This application discloses anti-PMEL17 antibodies, antigen binding fragments thereof, and antibody drug conjugates comprising antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The application also outlines methods of treating or preventing cancer using these antibodies, antigen binding fragments, and antibody drug conjugates. Additionally, it includes methods for making the antibodies and their use as diagnostic reagents.
Career Highlights
Eusebio is currently employed at Novartis AG, a leading global healthcare company. His work focuses on developing innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.
Collaborations
Eusebio has collaborated with notable colleagues, including Matthew T Burger and Joseph Anthony D'Alessio. These partnerships have contributed to the success of his research and the development of effective cancer therapies.
Conclusion
Eusebio Manchado Robles is a distinguished inventor whose work in antibody development is paving the way for new cancer treatments. His innovative approach and dedication to research continue to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile